INTRODUCTION
In developing countries, measles causes high rates of morbidity and mortality in chil age, has produced different results in the different geographic areas studied. In São Paulo, the seroconversion rate is approximately 80% 19 23 showing that there are still a great number of children susceptible after vaccination. The use of a second dose, for children above one year old, could solve this problem. However it has been suggested by some authors 15 37 that a percentage of the children vaccinated before 12 months of age do not respond adequately to a later second dose. If this is confirmed, then a vaccination program that included two doses, the first one given before one year of age, would have to be immediately dropped.
All these facts demonstrate deep controversies as to the ideal age for vaccination against measles in developing countries 35 , and show that there are still few field studies on this subject.
The object of this study is to compare the hospital files. The parents were also asked to consent to the drawing of a blood sample from the child.
The 242 children were divided into three groups according to the ages at which they had received measles vaccination. In Table 2 we have the number of children in each group exposed to measles after vaccina The mean titer of antibodies in children v cinated with one dose given at 12 months of a or more (Group C) was similar to that obtain from children who had received an early do and were revaccinated at 12 months of age more (Group A). This shows that there see to be no negative serologic effect of an early do (given before 12 months of age) on the effica 
